Literature DB >> 19164128

Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.

Sanna M Mäkelä1, Mari Strengell, Taija E Pietilä, Pamela Osterlund, Ilkka Julkunen.   

Abstract

TLRs are innate immune receptors that recognize pathogen-associated structures. Binding of ligands to different TLRs can induce the production of proinflammatory cytokines in a synergistic manner. We have analyzed the molecular mechanisms of synergy in TLR ligand-stimulated human monocyte-derived macrophages and dendritic cells (moDCs). Stimulation of moDCs with the TLR8 ligand together with the TLR3 or TLR4 ligand led to synergistic IL-6, IL-10, IL-12, and TNF-alpha mRNA expression and cytokine production. DNA-binding assays showed that TLR3 and TLR8 stimulation induced binding of multiple IFN regulatory factor (IRF) and STAT transcription factors to the IL-12p35 gene promoter IFN-stimulated response element in moDCs and macrophages but with different binding profiles and kinetics. We also demonstrate that NF-kappaB, MAPKs and PI-3K pathways have an important role in TLR-induced cytokine gene expression, as pharmacological inhibitors of these signaling pathways inhibited TLR3, TLR4, and TLR8 ligand-induced cytokine mRNA expression and protein production. Especially, synergistic IL-12p70 production was abolished completely in NF-kappaB, MAPK p38, and PI-3K inhibitor-treated moDCs. Our data suggest that TLR-dependent, synergistic cytokine gene expression results from enhanced activation and cooperation among NF-kappaB, IRF, MAPK, PI-3K, and STAT signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164128     DOI: 10.1189/jlb.0808503

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  70 in total

1.  GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

Authors:  Hayedeh Behzad; Anke L W Huckriede; Laura Haynes; Beth Gentleman; Krysta Coyle; Jan C Wilschut; Tobias R Kollmann; Steven G Reed; Janet E McElhaney
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.

Authors:  Michael A Morse; Robert Chapman; John Powderly; Kimberly Blackwell; Tibor Keler; Jennifer Green; Renee Riggs; Li-Zhen He; Venky Ramakrishna; Laura Vitale; Biwei Zhao; Stephen A Butler; Amy Hobeika; Takuya Osada; Thomas Davis; Timothy Clay; H Kim Lyerly
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

Review 3.  The response of human dendritic cells to co-ligation of pattern-recognition receptors.

Authors:  Tanja Dzopalic; Ivan Rajkovic; Ana Dragicevic; Miodrag Colic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 4.  The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

Authors:  Craig L Slingluff
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

5.  Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.

Authors:  Jiawei Zhao; Manjunatha R Benakanakere; Kavita B Hosur; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  Mol Immunol       Date:  2010-08-21       Impact factor: 4.407

Review 6.  The molecular mechanisms of TLR-signaling cooperation in cytokine regulation.

Authors:  Qian Liu; Jeak Ling Ding
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

7.  HIV-1-neutrophil interactions trigger neutrophil activation and Toll-like receptor expression.

Authors:  Diana Marcela Giraldo; Juan Carlos Hernandez; Paula Velilla; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Authors:  Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby
Journal:  Am J Reprod Immunol       Date:  2017-06-20       Impact factor: 3.886

9.  TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10.

Authors:  Ileana S Mauldin; Ena Wang; Donna H Deacon; Walter C Olson; Yongde Bao; Craig L Slingluff
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

Review 10.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.